IP Verse

Insulinotropic And Glucagonotropic Effects Of Beta-Lactoglobulin

Patent No. EP4061399 (titled "Insulinotropic And Glucagonotropic Effects Of Beta-Lactoglobulin") was filed by Arla Foods Amba on Nov 20, 2020. The application was issued on Feb 14, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZIMMERMANN & PARTNER PATENTANWALTE MBBNov 14, 2024ZIMMERMANN & PARTNER PATENTANWALTE MBB
NUTRICIANov 13, 2024NEDERLANDSCH OCTROOIBUREAU

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4061399

ARLA FOODS AMBA
Application Number
EP20808127A
Filing Date
Nov 20, 2020
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register , Google Patents